Sertraline with multi-strain probiotics for adolescents with depression
Official title: A Study on the Efficacy and Safety of Sertraline Combined With Multi-Strain Probiotics in Treating Adolescent Patients With Depression: A Multi-Center Randomized Controlled Clinical Trial
Run by First Affiliated Hospital of Chongqing Medical University · NCT07645157 · Data updated 2026-11-12
This study tests whether adding multi-strain probiotics to sertraline helps teens (ages 12–18) with major depressive disorder feel better than sertraline with a placebo.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 12 Years to 18 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | First Affiliated Hospital of Chongqing Medical University Academic / other |
| Locations | 1 site (Chongqing, Yuzhong) |
| Status | Recruiting |
| Started | October 1, 2026 |
| Main results expected | October 1, 2028 |
| Study ends | October 1, 2028 |
| Registry record updated | June 12, 2026 |
| Trial ID | NCT07645157 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adolescents aged 12–18 with a DSM-5-confirmed major depressive disorder and moderate baseline symptoms.
✕Probably not a fit
Individuals with significant comorbid psychiatric or major physical illnesses or who have not responded to two antidepressants may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this phase 2 trial, adolescents with major depressive disorder will receive either sertraline plus multi-strain probiotics or sertraline plus placebo for 8 weeks, with clinical visits every four weeks for safety and symptom assessments. Participants must meet DSM-5 criteria for MDD and have moderate depressive symptoms at baseline. The study aims to determine if the probiotic addition provides additional benefit beyond sertraline alone. The primary endpoint is improvement in depressive symptoms compared to the control group, with safety monitoring throughout.
Why it matters
Potential benefit: If successful, the combination could offer greater symptom relief for adolescents with depression than sertraline alone.
How similar studies have gone: Previous research in adults has explored probiotics as adjuncts to antidepressants, with mixed results; this trial applies the approach to a pediatric population and remains exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Aged 12-18 years * Meets DSM-5 criteria for major depressive disorder (MDD) and is currently in a depressive episode according to the Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version (K-SADS-PL) interviews * Child Depression Rating Scale-Revised (CDRS-R) score ≥40 at baseline * Clinical Global Impression Scale (CGI-S) score ≥ 4 at baseline Exclusion Criteria: * • Presence of any comorbid psychiatric disorder according to DSM-5, other than anxiety disorders * MDD with psychotic symptoms * Young Mania Rating Scale (YMRS) \>13 at baseline * History of neurological disorders (e.g., epilepsy, traumatic brain injury), or the presence of serious physical illnesses (e.g., thyroid disease, lupus erythematosus, diabetes mellitus, clinically significant pulmonary, hepatic, or renal impairment, or major trauma) * Nonresponse to at least two antidepressants with different mechanisms, and each administered at an adequate dose and for an adequate duration * History of intolerance to sertraline or nonresponse to an adequate therapeutic course of sertraline * Current high suicide risk * History of alcohol or drug abuse or dependence * Taking or administering antidepressants within 5 half-lives * Use of probiotic-related food or medicine within 2 weeks before enrollment * Systemic use of antibiotics or antifungals within 1 month before enrollment * History of severe food allergy or known hypersensitivity to the Lactobacillus crispatus preparation or any of its components * Adherence to vegetarian or other restrictive dietary patterns * Pregnancy or breastfeeding
Where it's running
-
The Affiliated Hospital of Chongqing Medical University
Chongqing, Yuzhong, China Recruiting
Study contacts
- Study coordinator: Teng Teng
- Email: tengteng@hospital.cqmu.edu.cn
- Phone: +86 18883368354
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sertraline plus a probiotic (Lactobacillus crispatus) for teens with depression
This study tests whether adding Lactobacillus crispatus to sertraline helps reduce depressive symptoms in adolescents with major depressive disorder.
-
Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures
This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.
-
Temporally Interfering Electrical Stimulation for Major Depressive Disorder
This study tests whether noninvasive temporally interfering electrical stimulation can help people with major depressive disorder.
-
Affective Cognitive Training for mood disorders and their close relatives
A six-week program combining virtual reality and computer exercises tests whether affective cognitive training helps people with mood disorders and their unaffected first-degree relatives.
-
ALKS 7290 added to antidepressants for adults with major depression
This study tests whether ALKS 7290, taken with current antidepressants, helps adults with major depressive disorder.
-
French Minds: a French, Multimodal Cohort Study of Severe Psychiatric Disorders and Healthy Controls
This study tests whether people with mood, psychotic, or autism disorders can be grouped into more similar subtypes based on social withdrawal and anhedonia, across ages 15 to 60.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.